ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 407 filers reported holding ENCOMPASS HEALTH CORP in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $247,991 | -44.7% | 4,040 | -44.7% | 0.01% | -44.4% |
| Q4 2022 | $448,512 | -19.0% | 7,300 | -38.4% | 0.01% | -30.8% |
| Q3 2022 | $554,000 | +1.8% | 11,850 | +5.4% | 0.01% | +8.3% |
| Q2 2022 | $544,000 | -19.9% | 11,245 | +19.3% | 0.01% | -7.7% |
| Q1 2022 | $679,000 | +35.8% | 9,424 | +21.4% | 0.01% | +44.4% |
| Q4 2021 | $500,000 | +29.2% | 7,765 | +34.4% | 0.01% | +28.6% |
| Q3 2021 | $387,000 | +2.7% | 5,779 | +23.1% | 0.01% | 0.0% |
| Q2 2021 | $377,000 | +60.4% | 4,696 | +63.9% | 0.01% | -22.2% |
| Q1 2021 | $235,000 | +5.9% | 2,865 | -18.4% | 0.01% | -25.0% |
| Q3 2019 | $222,000 | -48.8% | 3,510 | -48.7% | 0.01% | -52.0% |
| Q2 2019 | $434,000 | -6.7% | 6,847 | -14.0% | 0.02% | -16.7% |
| Q1 2019 | $465,000 | -16.8% | 7,959 | +11.0% | 0.03% | -30.2% |
| Q3 2018 | $559,000 | +4.1% | 7,172 | -9.6% | 0.04% | -8.5% |
| Q2 2018 | $537,000 | +26.1% | 7,933 | +6.6% | 0.05% | +20.5% |
| Q1 2018 | $426,000 | – | 7,443 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |